Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Pak J Pharm Sci ; 36(2): 397-407, 2023 Mar.
Article in English | MEDLINE | ID: mdl-37530146

ABSTRACT

The present study aimed to evaluate the effect of a mouthwash containing a novel compound Chinese herbal medicine (artemisia capillaris, chrysanthemum, honeysuckle, angelica dahurica and asarum sieboldii) on oral ulcers and analyze sub chronic oral toxicity in rats. For efficacy study, mouthwash was administered on the ulcer area twice daily. Compared with the control group, healing time in the test group was shorter and the ulcer area was smaller. Histological analysis showed less inflammatory cell infiltration in the test group. For sub chronic oral toxicity, mouthwash was administered by oral gavage for 93 consecutive days. There were no significant differences in body weight, food consumption or organ coefficients between the test and control groups. Some parameters of haematology and serum chemistry were statistically different but within normal physiological ranges. No obvious abnormalities were found in the necropsies and histopathological observations. In conclusion, the compound Chinese herbal medicine mouthwash promoted oral ulcer healing in rats with no obvious sub chronic toxicity, providing a potential alternative therapeutic strategy for oral ulcers.


Subject(s)
Drugs, Chinese Herbal , Oral Ulcer , Rats , Animals , Rats, Sprague-Dawley , Drugs, Chinese Herbal/therapeutic use , Drugs, Chinese Herbal/toxicity , Mouthwashes , Oral Ulcer/chemically induced , Oral Ulcer/drug therapy , Ulcer
2.
Nutrients ; 14(1)2021 Dec 22.
Article in English | MEDLINE | ID: mdl-35010903

ABSTRACT

Salvadora persica L. (S. persica, Siwak) is an ethnic plant that is widely used for improving oral hygiene. This study aimed to provide a phytochemical profiling of S. persica ethyl acetate fraction (SPEAF) and to evaluate the healing activity of a muco-adhesive formula of the fraction against acetic acid-induced oral ulcers in rats. HPLC-ESI-QTOF-MS-MS analysis of SPEAF resulted in the tentative identification of 56 metabolites containing fatty acids (23%), urea derivatives (10.5%) and sulphur compounds (10%), in addition to several amides, polyphenols and organic acids (6.5%, 5% and 2%, respectively). For the first time, 19 compounds were identified from S. persica. In vitro and in vivo experiments indicated that the extract is non-toxic. SPEAF exhibited superior healing activities compared to both the negative and positive control groups on days 7 and 14 of tongue ulcer induction. This was confirmed by histopathological examinations of haematoxylin and eosin-stained (H&E) and Masson's trichrome-stained tongue sections. Moreover, SPEAF showed potent anti-inflammatory activities, as evidenced by the inhibited expression of interleukin-6 (IL-6) and tumour necrosis alpha (TNF-α). Moreover, SPEAF exhibited potent antioxidant activity, as it prevented malondialdehyde (MDA) accumulation, reduced glutathione (GSH) depletion and superoxide dismutase (SOD) exhaustion. SPEAF significantly enhanced hydroxyproline tongue content and upregulated collagen type I alpha 1 (Col1A1) mRNA expression. SPEAF also improved angiogenesis, as shown by the increased mRNA expression of the angiopoietin-1 (Ang-1). In conclusion, S. persica has a wide range of secondary metabolites and ameliorates acetic acid-induced tongue ulcers in rats. This can be attributed, at least partly, to its anti-inflammatory, antioxidant, procollagen and angiogenic activities. These findings provide support and validity for the use of S. persica as a traditional and conventional treatment for oral disorders.


Subject(s)
Acetic Acid/toxicity , Oral Ulcer/chemically induced , Oral Ulcer/drug therapy , Plant Extracts/pharmacology , Salvadoraceae/chemistry , Wound Healing/drug effects , Adhesives , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants , Chromatography, High Pressure Liquid , Male , Mass Spectrometry , Oxidative Stress , Plant Extracts/chemistry , Random Allocation , Rats , Rats, Wistar
4.
J Mol Histol ; 51(4): 341-352, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32472334

ABSTRACT

Caustic ingestion is a potentially detrimental event that can cause serious devastating damage on contact with tissues. Local exposure is associated with severe pain, swelling and ulceration. Caustics-induced oral ulcers can be painful enough to compromise the patient's quality of life. Treatment of oral ulcers is crucial in clinical practice. Albeit, some ulcers do not respond adequately to the conventional treatment. The current study was conducted to evaluate the potential healing effects of topical Salvadora persica (SP) extract, low-level laser (LLL) and high-level laser (HLL) therapies in a rabbit model of caustic-induced tongue ulcers and explore the underlying mechanisms. Fifty male rabbits with a caustic induced tongue ulcers were included in the study. Rabbits were equally divided into four groups: positive control (ulcer) group, SP, LLL and HLL groups in addition to the negative control (healthy) group. All treatments were given thrice weekly for 14 days. Results showed that acetic acid-induced tongue ulcers caused extensive structural tongue damage secondary to overexpression of apoptotic BAX, pathological angiogenesis indicated by VEGF overexpression, marked collagen fibers deposition as well as upregulation of tissue pro-inflammatory TNF-α and upregulation of tissue anti-inflammatory IL-10. The healing potential of topical SP, LLL and HLL therapy are mostly comparable. In conclusion, acetic acid-induced extensive tongue damage. Topical SP extract, LLL and HLL are equally effective therapies against caustics-induced tongue ulcers. However, we recommend SP extract, owing to its safety, non-invasiveness, availability and low cost.


Subject(s)
Caustics/pharmacology , Oral Ulcer/drug therapy , Oral Ulcer/therapy , Plant Extracts/pharmacology , Salvadoraceae/chemistry , Animals , Anti-Inflammatory Agents/pharmacology , Laser Therapy/methods , Male , Oral Ulcer/chemically induced , Quality of Life , Rabbits , Tongue/drug effects , Wound Healing/drug effects
5.
J Clin Pharm Ther ; 45(1): 214-217, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31545520

ABSTRACT

WHAT IS KNOWN AND OBJECTIVE: Low-dose methotrexate (LDMTX) has been widely used for many decades in clinical settings, with good safety profiles compared with those of high-dose methotrexate. LDMTX is also used as one of the off-label conservative therapies in treating placenta accreta (PA). Until now, only a few mild adverse drug reactions (ADRs) have been published after short-term use of LDMTX, and no severe cases have been reported. CASE SUMMARY: We present a case of a 30-year-old female who developed acute severe oral ulcerative mucositis with degree IV myelosuppression and degree III hepatic injury, after three doses of LDMTX to treat placenta accrete. The symptoms gradually improved after leucovorin rescue and supportive treatments. WHAT IS NEW AND CONCLUSION: The present case provides the first severe ADR report for the short-term use of LDMTX for treating PA, indicating that potentially life-threatening complications can also occur when using LDMTX. Early recognition and immediate leucovorin rescue could result in a favourable outcome.


Subject(s)
Methotrexate/adverse effects , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Oral Ulcer/chemically induced , Stomatitis/chemically induced , Adult , Dose-Response Relationship, Drug , Female , Humans , Leucovorin/administration & dosage , Methotrexate/administration & dosage , Mutation , Oral Ulcer/pathology , Placenta Accreta/drug therapy , Pregnancy , Severity of Illness Index , Stomatitis/pathology
6.
Pediatr Med Chir ; 40(2)2018 Sep 26.
Article in English | MEDLINE | ID: mdl-30256054

ABSTRACT

Alchornea cordifolia is known to be a plant with a variety of medicinal properties and is quoted by many traditional healers to treat a variety of medicinal problems in the Democratic Republic of Congo. However, very little is known about its potential toxicity. We report the case of a 9-year-old boy referred for assessment of suspected bronchial troubles without a history of atopic disease or drug allergy who developed dyspnea, dysphagia, asthenia and lingual ulcers within 30 minutes after nasal and oral administration of decoction of palm oil associated with A. cordifolia leaves in water. In the present report, adverse effects of A. cordifolia therapy may be related to the mixtures of active compounds that they contain and can cause the symptoms observed in our patient. These findings call for caution in the use of A. cordifolia especially in children.


Subject(s)
Euphorbiaceae/chemistry , Palm Oil/adverse effects , Plant Extracts/adverse effects , Administration, Oral , Asthenia/chemically induced , Child , Deglutition Disorders/chemically induced , Dyspnea/chemically induced , Humans , Male , Oral Ulcer/chemically induced , Palm Oil/administration & dosage , Plant Extracts/administration & dosage , Plant Leaves
7.
Lasers Med Sci ; 30(1): 389-96, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25354753

ABSTRACT

The aim of this study was to evaluate, clinically and histologically, the influence of laser and LED photobiomodulation in the healing of formocresol-induced oral mucosa ulcers of rats. We used 60 Wistar rats in which oral ulcers were induced on the gingiva of the lower incisors. Forty-eight hours after inducing the ulcers, the animals were divided into three groups: laser, LED, and untreated. Animals from the laser group received irradiation with GaAlAs, 660 nm, CW, 40 mW, φ 4 mm(2), 4.8 J/cm(2). Animals from the LED group received irradiation with InGaAIP, 630 nm, 150 mW, 4.8 J/cm(2), 0.8 cm spot. Forty-eight hours after oral ulcer induction, both irradiations were applied in a punctuate manner in the center of the ulcer at 48-h interval until the end of the experimental period. The animals were killed at 3, 5, 7, and 11 days after day 0. The results of the clinical evaluation showed that the laser and LED phototherapies were able to accelerate the healing of formocresol-induced oral ulcers, which occurred first in the laser group (ANOVA, p < 0.05). Histologically, there was a slight variation between LED and laser therapy; therefore, the laser group proved to be effective in accelerating wound healing, especially at 5 days, whereas the LED group was more effective at the end of the experimental period. It was concluded that laser and LED photobiomodulation were effective in accelerating the healing of formocresol-induced oral ulcers in both clinical and histological aspects.


Subject(s)
Low-Level Light Therapy , Oral Ulcer/pathology , Oral Ulcer/radiotherapy , Animals , Collagen/metabolism , Formocresols , Male , Oral Ulcer/chemically induced , Rats, Wistar , Wound Healing/radiation effects
8.
Clin Interv Aging ; 9: 737-40, 2014.
Article in English | MEDLINE | ID: mdl-24812499

ABSTRACT

OBJECTIVE: To report a series of cases of ulceration of the oral mucosa linked to direct contact with ferrous sulfate in elderly patients. CASE SUMMARY: The first case report concerns the occurrence of widespread oral ulceration in an 87-year-old woman with Alzheimer's disease. The ulceration extended from the side of the tongue to the floor of the mouth. No clear explanation was found and various local treatments were ineffective. Once it was realized that the ferrous sulfate tablets (given as an iron supplement) were crushed prior to administration (due to the patient's deglutition disorder), withdrawal of this treatment led to rapid resolution of the ulceration. Nine other cases of oral ulcerations associated with ferrous sulfate were identified in the French National Pharmacovigilance Database. All but one of the patients were over 80 years of age and the youngest patient (a 54-year-old) had dysphagia associated with facial paralysis. DISCUSSION: Only two other reports of oral ulceration due to ferrous sulfate have been published to date. Mucosal toxicity of ferrous sulfate (which is probably related to oxidative stress) has previously been reported for the hypopharynx, the esophageal lumen, and (after inhalation of a tablet) the tracheobronchial tree. CONCLUSION: The mucosal toxicity of ferrous sulfate must be taken into account when deglutition disorders are present (as in elderly patients) and appropriate pharmaceutical formulations (such as syrups) should be administered to at-risk patients. The use of iron salts other than ferrous sulfate could be considered.


Subject(s)
Ferrous Compounds/adverse effects , Mouth Mucosa/drug effects , Oral Ulcer/chemically induced , Adverse Drug Reaction Reporting Systems/statistics & numerical data , Aged, 80 and over , Alzheimer Disease/complications , Databases, Factual , Dietary Supplements/adverse effects , Female , France/epidemiology , Humans , Oral Ulcer/complications , Tablets
9.
Int J Pharm ; 450(1-2): 338-44, 2013 Jun 25.
Article in English | MEDLINE | ID: mdl-23583503

ABSTRACT

The aim of this study was to prepare riboflavin laurate (RFL) nanosuspensions as an intramuscular injection for long-term riboflavin supplementation. Stable RFL nanosuspensions were obtained by injecting RFL/poloxamer solution in N,N-dimethyl formamide into a trehalose solution. Long soft nanostructures initially appeared and then tube-like rigid nanostructures were obtained after removal of solvents according to the transmission electron microscopic images. The nanosuspensions had narrow size distribution and the mean size was about 300 nm. Molecular self-assembly of RFL may drive the formation of nanostructures. RFL formed a monolayer at the air/water interface and poloxamer 188 could insert into the monolayer. The nanosuspensions were intramuscularly injected into rats to provide long-term riboflavin supplementation for more than 30 days in light of body weight, food intake, and urinary riboflavin. The nanosuspensions were also used to resist the riboflavin deficiency induced by methotrexate chemotherapy. RFL nanosuspensions are a promising nanomedicine for long-term riboflavin supplementation.


Subject(s)
Laurates/administration & dosage , Riboflavin/administration & dosage , Vitamin B Complex/administration & dosage , Animals , Dietary Supplements , Injections, Intramuscular , Laurates/pharmacokinetics , Laurates/urine , Male , Methotrexate , Nanostructures/administration & dosage , Oral Ulcer/chemically induced , Oral Ulcer/prevention & control , Rats , Rats, Sprague-Dawley , Riboflavin/pharmacokinetics , Riboflavin/urine , Riboflavin Deficiency/chemically induced , Riboflavin Deficiency/prevention & control , Suspensions , Vitamin B Complex/pharmacokinetics , Vitamin B Complex/urine
10.
Article in English | MEDLINE | ID: mdl-23601229

ABSTRACT

BACKGROUND: The differential diagnosis of ulcerative oral lesions is diverse. This report discusses the rare causes of oral mucosal ulceration and suggests approaches for diagnosis and treatment. METHODS: Two cases of methotrexate-induced stomatitis in patients receiving low dose methotrexate for rheumatoid arthritis are presented with a review of the current literature. In case 1, mucositis was caused by an unintended methotrexate overdose. In case 2, oral lesions were the result of chronic methotrexate toxicity. The treatment for methotrexate-induced mucositis required hospitalization in case 1, methotrexate discontinuation in both cases and oral folic acid supplementation in case 2. RESULTS: In both cases, the mucositis healed and no relapse was observed. CONCLUSION: Mucositis may be an early sign of systemic conditions, and dental providers are often the first doctors involved in the assessment of oral mucosal diseases. Meticulous questioning of the patient's history and the physical examination is important for elucidating the underlying cause.


Subject(s)
Antirheumatic Agents/adverse effects , Arthritis, Rheumatoid/drug therapy , Methotrexate/adverse effects , Oral Ulcer/chemically induced , Stomatitis/chemically induced , Aged , Aged, 80 and over , Antirheumatic Agents/administration & dosage , Antirheumatic Agents/poisoning , Diagnosis, Differential , Drug Overdose/complications , Female , Folic Acid/therapeutic use , Follow-Up Studies , Gingivitis, Necrotizing Ulcerative/chemically induced , Hospitalization , Humans , Lip Diseases/chemically induced , Methotrexate/administration & dosage , Methotrexate/poisoning , Skin Ulcer/chemically induced , Stomatitis, Herpetic/diagnosis , Tongue Diseases/chemically induced
11.
Article in English | MEDLINE | ID: mdl-23182376

ABSTRACT

OBJECTIVE: This study assessed the potential of topical Calendula officinalis extract on the healing of oral mucositis induced by 5-fluorouracil (5-FU) in hamsters. STUDY DESIGN: Oral mucositis was induced in 60 male hamsters by 5-FU (60 mg/kg) on days 0, 5, and 10 of the study. The cheek pouch was scratched with a sterile needle on days 1 and 2. On days 12-17, 5% and 10% C. officinalis gel and gel base groups were treated and then compared with a control group. Macroscopic and microscopic scores and weights were evaluated. RESULTS: Microscopic and macroscopic scores of mucositis were lower in the 5% and 10% C. officinalis gel groups than in the gel base and control groups (P < .05). Weight gain was noted in the treatment groups compared with the gel base and control groups (P < .05). CONCLUSIONS: Calendula officinalis extract accelerated the healing of oral mucositis in hamsters.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Calendula , Fluorouracil/adverse effects , Phytotherapy/methods , Plant Extracts/therapeutic use , Stomatitis/drug therapy , Abscess/chemically induced , Abscess/pathology , Animals , Antimetabolites, Antineoplastic/administration & dosage , Carboxymethylcellulose Sodium , Cricetinae , Drug Carriers , Erythema/chemically induced , Erythema/pathology , Fluorouracil/administration & dosage , Gels , Hyperemia/chemically induced , Hyperemia/pathology , Injections, Intraperitoneal , Male , Mesocricetus , Mouth Diseases/chemically induced , Mouth Diseases/pathology , Mouth Mucosa/drug effects , Mouth Mucosa/injuries , Mouth Mucosa/pathology , Oral Hemorrhage/chemically induced , Oral Hemorrhage/pathology , Oral Ulcer/chemically induced , Oral Ulcer/pathology , Re-Epithelialization/drug effects , Single-Blind Method , Stomatitis/chemically induced , Stomatitis/pathology , Time Factors , Weight Gain , Wound Healing/drug effects
12.
Eur Arch Paediatr Dent ; 12(2): 118-23, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21473845

ABSTRACT

AIM: The goal of this pilot study was to investigate the capacity of pain relief and wound healing of low level laser therapy (LLLT) in chemotherapy-induced oral mucositis (OM) in a paediatric oncology population group. STUDY DESIGN AND METHODS: 16 children (mean age 9.4 years) from the Gent University Hospital - Department Paediatric Oncology/haematology, suffering from chemotherapy-induced OM were selected. During clinical investigations, the OM grade was assessed using the WHO classification. All children were treated using a GaAlAs diode laser with 830 nm wavelength and a potency of 150 mW. The energy released was adapted according to the severity of the OM lesions. The same protocol was repeated every 48 hrs until healing of each lesion occurred. Subjective pain was monitored before and immediately after treatment by an appropriate pain scale and functional impairment was recorded. At each visit, related blood cell counts were recorded. RESULTS: After 12 mths, records were evaluated and information about treatment sequence, treatment sessions and frequencies related to the pain sensation and comfort were registered. Immediately after beaming the OM, pain relief was noticed. Depending on the severity of OM, on average, 2.5 treatments per lesion in a period of 1 week were sufficient to heal a mucositis lesion. CONCLUSIONS: LLLT, one of the most recent and promising treatment therapies, has been shown to reduce the severity and duration of mucositis and to relieve pain significantly. In the present study similar effects were obtained with the GaAlAs 830nm diode laser. It became clear that using the latter diode device, new guidelines could be developed as a function of the WHO-OM grades i.e. the lower the grade, the less energy needed. Immediate pain relief and improved wound healing resolved functional impairment that was obtained in all cases.


Subject(s)
Low-Level Light Therapy/methods , Stomatitis/radiotherapy , Antineoplastic Agents/adverse effects , Child , Erythema/chemically induced , Erythema/radiotherapy , Female , Follow-Up Studies , Humans , Lasers, Semiconductor/therapeutic use , Leukemia/drug therapy , Leukocyte Count , Lymphoma/drug therapy , Male , Mouth Mucosa/drug effects , Mouth Mucosa/radiation effects , Necrosis , Neutrophils/pathology , Oral Hygiene , Oral Ulcer/chemically induced , Oral Ulcer/radiotherapy , Osteosarcoma/drug therapy , Osteosarcoma/surgery , Pain/chemically induced , Pain/radiotherapy , Pain Measurement , Pilot Projects , Platelet Count , Radiotherapy Dosage , Stomatitis/chemically induced , Time Factors , Wound Healing/radiation effects
13.
Eur Arch Paediatr Dent ; 12(2): 124-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21473846

ABSTRACT

BACKGROUND: Oral mucositis is the main complication of chemotherapy and radiotherapy used in the treatment of cancer. Phototherapy has proven effective in the treatment of mucositis, as it accelerates the tissue healing process and has both analgesic and anti-inflammatory properties. CASE REPORT: This paper reports the case of a paediatric patient with oral mucositis stemming from chemotherapy employed for the treatment of acute lymphoblastic leukaemia. TREATMENT: The lesions were treated daily with a light-emitting diode (LED). FOLLOWUP: Remission of the lesions occurred after 10 days of treatment. CONCLUSIONS: LED was effective in the treatment of mucositis, as it diminished pain symptoms and accelerated the tissue repair process.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Low-Level Light Therapy/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Stomatitis/chemically induced , Analgesia , Anti-Inflammatory Agents , Cellulitis/chemically induced , Cellulitis/radiotherapy , Child, Preschool , Female , Hand Dermatoses/chemically induced , Hand Dermatoses/radiotherapy , Humans , Lasers, Semiconductor/therapeutic use , Lip Diseases/chemically induced , Lip Diseases/radiotherapy , Oral Ulcer/chemically induced , Oral Ulcer/radiotherapy , Pain Measurement , Remission Induction , Stomatitis/radiotherapy , Tongue Diseases/chemically induced , Tongue Diseases/radiotherapy , Wound Healing/radiation effects
14.
J Can Dent Assoc ; 74(5): 445-61, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18538070

ABSTRACT

Allergic contact stomatitis is a rare disorder that is unfamiliar to most clinicians. The vast majority of cases are associated with consumption of products containing cinnamaldehyde or cinnamon essential oil, which are used as flavourings because of their pleasant taste and sensation of freshness. We report here the case of a patient who was diagnosed with alllergic contact stomatitis due to cinnamon-flavoured chewing gum. The clinical features of allergic contact stomatitis, which may occur indiscriminately on any of the oral mucosa, include edema and erythroplakic, ulcerous or hyperkeratotic changes, generally accompanied by a burning sensation. The histopathologic aspect of allergic contact stomatitis is nonspecific but tends to support the clinical diagnosis. Treatment generally consists of eliminating the causal agent. To avoid unnecessary diagnostic procedures and treatments, it is important for clinicians to recognize this disorder to be able to diagnose it quickly and accurately.


Subject(s)
Chewing Gum/adverse effects , Cinnamomum zeylanicum/adverse effects , Dermatitis, Allergic Contact/complications , Flavoring Agents/adverse effects , Hypersensitivity/complications , Stomatitis/chemically induced , Adult , Dermatitis, Allergic Contact/pathology , Diagnosis, Differential , Female , Humans , Hypersensitivity/pathology , Oral Ulcer/chemically induced , Oral Ulcer/pathology , Plant Oils/adverse effects , Stomatitis/pathology
15.
Oral Health Prev Dent ; 5(1): 63-71, 2007.
Article in English | MEDLINE | ID: mdl-17366763

ABSTRACT

PURPOSE: To present an animal model for mucositis induced by fluorouracil in rats, and test two therapeutic options, the GaAIAs laser and topical dexamethasone, analysing them with regard to the quality and quantity of tissue alterations and comparing them with the phases of mucositis. MATERIALS AND METHODS: Forty-five Wistar rats (250 g) were treated with fluorouracil (60 mg/kg) and, in order to mimic the clinical effect of chronic irritation, the palatal mucosa was irritated by superficial scratching with an 18-gauge needle. When all of the rats presented oral ulcers of mucositis, they were randomly allocated to one of three groups: group I was treated with laser (GaAIAs), group II was treated with topical dexamethasone, and group III was not treated. Excisional biopsies of the palatal mucosa were then performed, and the rats were killed. Tissue sections were stained with haematoxylin and eosin for morphological analyses, and with toluidine blue for mast-cell counts. RESULTS: Group I specimens showed higher prevalence of ulcers, bacterial biofilm, necrosis and vascularisation, while group II specimens showed higher prevalance of granulation tissue formation. There were no significant statistical differences in the numbers of mast cells and epithelial thickness between groups. CONCLUSION: For the present model of mucositis, rats with palatal mucositis treated with laser (GaAIAs) showed characteristics compatible with the ulcerative phase of oral mucositis, and rats treated with topical dexamethasone showed characteristics compatible with the healing phase of mucositis. Topical dexamethasone was more efficient in the treatment of rats' oral mucositis than the laser.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antimetabolites/adverse effects , Dexamethasone/therapeutic use , Fluorouracil/adverse effects , Glucocorticoids/therapeutic use , Low-Level Light Therapy/methods , Stomatitis/radiotherapy , Aluminum , Animals , Arsenicals , Biofilms/drug effects , Biofilms/radiation effects , Disease Models, Animal , Gallium , Granulation Tissue/drug effects , Granulation Tissue/radiation effects , Male , Mouth Mucosa/drug effects , Mouth Mucosa/pathology , Mouth Mucosa/radiation effects , Necrosis , Oral Ulcer/chemically induced , Oral Ulcer/drug therapy , Oral Ulcer/radiotherapy , Random Allocation , Rats , Rats, Wistar , Stomatitis/chemically induced , Stomatitis/drug therapy , Wound Healing/drug effects , Wound Healing/radiation effects
17.
Eur J Pharmacol ; 551(1-3): 152-5, 2006 Dec 03.
Article in English | MEDLINE | ID: mdl-17046745

ABSTRACT

Oral ulcerative mucositis is a common and painful toxicity associated with chemotherapy for cancer. Current treatment for chemotherapy-induced oral mucositis is largely palliative, and no adequate treatment with conclusive evidence exists. The purpose of this study was to evaluate the potential effectiveness of the topical external medicines used in clinical settings, and the authors investigated the effects of 1% azulene ointment, 0.12% dexamethasone ointment, and polaprezinc-sodium alginate suspension on an animal model for oral mucositis induced by chemotherapy. Oral mucositis was induced in hamsters through a combination treatment of 5-fluorouracil and mild abrasion of the cheek pouch. Each drug was administered topically to the oral mucosa of hamsters, and the process of healing of damaged oral mucositis was examined by measuring the size of the mucositis. Azulene ointment did not reduce the size of the mucositis compared with the vaseline-treated control group. Polaprezinc-sodium alginate suspension significantly improved the recovery from 5-fluorouracil-induced damage. In contrast, local treatment with dexamethasone exacerbated the mucositis markedly. These results suggested the healing effect of polaprezinc-sodium alginate suspension and the risk of steroids to severe oral mucositis induced by chemotherapy.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Anti-Ulcer Agents/therapeutic use , Antimetabolites, Antineoplastic/adverse effects , Fluorouracil/adverse effects , Oral Ulcer/drug therapy , Stomatitis/drug therapy , Administration, Topical , Alginates , Analysis of Variance , Animals , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/pharmacology , Anti-Ulcer Agents/pharmacology , Area Under Curve , Azulenes/therapeutic use , Body Weight/drug effects , Carnosine/analogs & derivatives , Carnosine/therapeutic use , Cricetinae , Dexamethasone/therapeutic use , Drug Carriers , Drug Evaluation, Preclinical , Glucuronic Acid , Hexuronic Acids , Mesocricetus , Oral Ulcer/chemically induced , Oral Ulcer/pathology , Organometallic Compounds/therapeutic use , Stomatitis/chemically induced , Stomatitis/pathology , Time Factors , Zinc Compounds/therapeutic use
18.
Can Vet J ; 47(6): 579-82, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16808232

ABSTRACT

A 20-month-old German shepherd with primary pancreatic acinar atrophy and exocrine pancreatic insufficiency that was treated with pancreatic enzyme supplementation, vitamin B12, and cimetidine developed oral bleeding. Following discontinuation of the cimetidine, increased preincubation of the enzymes with the food, and symptomatic therapy for the ulceration, the dog's condition improved.


Subject(s)
Cimetidine/adverse effects , Dog Diseases/chemically induced , Enzyme Inhibitors/adverse effects , Oral Hemorrhage/veterinary , Oral Ulcer/veterinary , Animals , Atrophy/veterinary , Cimetidine/therapeutic use , Dogs , Enzyme Inhibitors/therapeutic use , Exocrine Pancreatic Insufficiency/drug therapy , Exocrine Pancreatic Insufficiency/veterinary , Male , Oral Hemorrhage/chemically induced , Oral Ulcer/chemically induced , Pancreas/enzymology , Vitamin B 12/therapeutic use
20.
Support Care Cancer ; 14(9): 974-6, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16502004

ABSTRACT

Study on the normal saline vs povidone-iodine mouthwashes for oral mucositis (OM) prophylaxis in patients after high-dose chemotherapy comprising bischloroethyl nitrosourea etoposide ara-C melphalan (BEAM) or high-dose melphalan (HD-L-PAM) followed by autologous peripheral stem cell transplantation indicated that females have higher a incidence of OM compared to men, as reported by [Vokurka et al. 13:554-558, (2005)]. The multivariable analysis of larger cohort of 148 patients compliant with the original study protocol confirmed female gender to be an independent risk factor and predictor for OM. The HD-L-PAM (200 mg/m2) conditioning regimen revealed to be more toxic compared to BEAM as for incidence of OM grades 3-4 World Health Organization score. Body mass index, age, mouthwash solution used, and CD34+ cell number in the autologous graft were verified not to have an impact on OM incidence in this group of patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Stomatitis/chemically induced , Stomatitis/epidemiology , Adolescent , Adult , Aged , Analysis of Variance , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carmustine/administration & dosage , Carmustine/adverse effects , Cytarabine/administration & dosage , Cytarabine/adverse effects , Etoposide/administration & dosage , Etoposide/adverse effects , Female , Humans , Incidence , Male , Melphalan/administration & dosage , Melphalan/adverse effects , Middle Aged , Multicenter Studies as Topic , Multivariate Analysis , Oral Ulcer/chemically induced , Oral Ulcer/epidemiology , Peripheral Blood Stem Cell Transplantation , Predictive Value of Tests , Randomized Controlled Trials as Topic , Risk Factors , Severity of Illness Index , Sex Factors , Transplantation, Autologous
SELECTION OF CITATIONS
SEARCH DETAIL